cardio labs Flashcards

(47 cards)

1
Q

vascular disease

A

all organs and tissue are potential targets of injury in vascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

blood vessel diseases

A

-Atherosclerosis
-HTN
-Vasculitis (inflammation)- autoimmune, infection -> can cause stroke (w/o any common risk factors!)
-Aneurysms
-Tumors- increase vascular supply to grow
-DVT
-PE
-Stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of atherosclerotic ds

A

Ingestion of excess fats in diet: MC
Primary Lipid disorders
- intake, genetics

Secondary Lipid disorders
- pancreatitis
- hypothyroidism, nephrotic syndrome, liver disease, diabetes, obesity, and alcohol abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

atherosclerosis: fasting lipid profile; what values are high

A

Need 8-12hr fast for blood draw
-Total Cholesterol - >200 (high)
-LDL- >200 (high) -> friedwald formula or direct assay
-HDL- you want it > 40
-Triglycerides- >190 (high)
-numbers diff by age, risk factors, gender

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LDL values

A

> 200 mg/dL is elevated
- Know LDL values in term with a clinical picture
~ 70 mg/dL in cardiac patients (recommended) QT
Friedewald Formula or direct assay*

pharm note:
- ideal is under 100
- high is greater than 160

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

lifestyle modifications: how to lower elevated LDL

A

-exercise
-smoking cessation
-target BMI
-diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

screening and managing hyperlipidemia chart: when to get fasting lipid profile?

A

-Triglycerides (TG) >250 mg/dL (>6.5 mmol/L).
-HDL cholesterol (HDL-C) <40 mg/dL (<1 mmol/L).
-Hx of hypertriglyceridemia
- On medications that elevate triglycerides (like estrogens, glucocorticoids).
- DM
- Fam Hx of genetic hyperlipidemia

next step: estimate cardiovascular risk with calculator and see if tx is warrented
- below threshold for tx: reassess lipids in 5 yrs
- near threshold: reassess in 3 yrs
- above threshold: tx high LDL and repeat LDL-C 6 wks post-tx and then every 6-12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

total cholesterol

A

TC = HDL + LDL + VLDL + IDL + Lp
- over 200 = elevated
-non specific
-is good cholesterol elevated?
-is bad cholesterol elevated?
-you never just look at this value

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HDL

A

Target > 40 mg/dL
Low levels represent a cardiac risk factor
> 60 reduces cardiac risk!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Triglycerides, when is it elevated?

A

> 190 mg/dL: elevated

Elevated in:
- pancreatitis*
- hypothyroidism
- nephrotic syndrome
- liver disease
- metabolic disorders
- toxemia

“can study for it before lipid panel” - more variable dependent on what you eat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

framingham score: what factors

A

-gold standard cardiovascular risk
-HDL is the only protective factor -> reduces risk of atherosclerotic disease
-memorize factors
- if they are on meds with HIGH BP -> uncontrolled*

Factors: “THAH Gold Standard”
- Total Cholesterol
- HDL
- Age
- HTN
- Gender
- Smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clinical picture flow chart

A

-clinical ASCVD- CAD, MI, PAD, cerebral vascular disease, carotid disease, renal artery stenosis
-primary prevention- preventing the first event
-secondary prevention- preventing a second even from happening
-know this chart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Secondary prevention: ASCVD

A

Very high risk (multiple major ASCVD events or one major ASCVD event plus multiple high-risk conditions),
- goal: MAX tolerated statin to achieve a 50% or more reduction in LDL-C
- if LDL-C levels are ≥70 mg/dL on statin: add ezetimibe -> add CSK9 inhibitor

stable ASCVD and less intensive risk factors:
- High intensity statin: > 50%
- moderate intensity: 30-49%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

primary prevention: intermediate LDL + no diabetes

A

40-75 yrs + LDL-C levels of 70-189 mg/dL without DM:
- risk of ASCVD within 10 years is done to determine the intensity of statin therapy

High Risk (≥20%):
- High-intensity statin aiming for ≥50% LDL-C reduction.
Intermediate Risk (7.5-19.9%):
- Moderate-intensity statin with a goal of 30-49% LDL-C reduction
Borderline Risk (5-7.4%):
- Risk discussion for statin benefits
- consider moderate-intensity statin if risk enhancers are present
Low Risk (<5%):
- Lifestyle changes
- statins based on individual risk factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

primary prevention: LDL > 190 mg/dL

A

tx: maximally tolerated statin
- if LDL > 100: add ezemtimibe -> PCSK9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the recommended statin therapy for individuals aged 40-75 with diabetes?

A

Start with a moderate-intensity statin
- possibility of escalating to high-intensity statin (50+ yrs, ASCVD risk factors)

Target: LDL-C reduction of 30-49% or ≥50% for those at higher risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

statin ADR

A

-muscle cramps
-elevated LFTs- 6 weeks lipid levels, and LFTs
-statins attack endogenous LDL- genetic cholesterol
-ezetimibe stops LDL absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

C-reactive protein

A

Persistent inflammatory process!
Increased risk of cardiovascular events based on CRP:
- <1.0 mg/L low risk
- 1-3 mg/L intermediate
- >3.0 mg/L high risk
- pts with inflammatory process will have CRP > 3
-Used to classify those patients who are at borderline CV risk
-is this due to vasculitis?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

metabolic syndrome

A

-Series of risk factors for cardiovascular disease ( MI, CVA, DM), kidney dysfunction,
- occurs 40% of US pts over 60 years of age!
-May not have any physical symptoms!!!

20
Q

metabolic syndrome criteria

A

At least 3 of the following:
-impaired glucose tolerance (pre-diabetes): fasting plasma glucose >=100 or A1c 5.6-6.4
-abdominal obesity
-hypertriglyceridemia- >=150 or on on meds for it
-low levels of HDL: <40 (men), <50 (women), or on meds for it
-HTN- >130/85, or on meds for it

21
Q

DUTCH dx criteria for familial/genetic hypercholesterolemia

A

6– Family hx of early heart disease or high cholesterol
- Clinical hx of premature CAD
-PE: tendinous xanthomata (yellow plaque) or corneal arcus (greyish ring around the eye) before a certain age
- Elevated LDL-C.
- DNA analysis revealing a functional mutation in relevant genes such as LDLR, apoB, or PCSK9.

higher score = more likely FH
->8: DEFINITIVE dx
-6-8: probably dx
- 3-5: possible dx

22
Q

Cardiovascular risk factors

A

-Smoking,
-Hypertension
-DM
-Obesity
-Physical inactivity
-Family History of coronary disease

23
Q

HTN: how common is it? correctable causes of HTN

A

In US: up to 50% of adults have HTN

Correctable causes of HTN:
-obesity
-tobacco
-Na+ intake*
-ETOH
-oral contraceptives
-NSAIDS

24
Q

HTN complications + secondary HTN

A

Microvascular damage
-chronic HTN can affect GFR / kidney function

Secondary: HTN caused by an underlying ds
-renal artery stenosis
-pheochromocytoma
-hyperaldosteronism
-hypothyroidism

25
vasculitis
Definition: inflammation of the blood vessel wall -decrease blood flow -> necrosis of tissue - associated with autoimmune rxns: antineutrophil cytoplasmic antibody, elevated ANA - MC presentation = skin changes and modeled lacy skin pattern - different forms of vasculitis are classified by the size of the vessels affected Primary: no underlying ethiology Secondary: - due to infection (HIV, Hep B, Hep C, - due to autoimmune (lupus, RA):
26
dx of vasculitis
Dx: - Presence of characteristics of particular clinical findings -Inflammation within particular size blood vessels - vessel bx + labs help dx Labs: -ANCA antibodies IgG (dont need to know this): systemic vasculitis -Elevated erythrocyte sedimentation rate (ESR) -C-reactive protein -End organ damage -antineutrophil cytoplasmic antibody, ANA
27
vasculitis sx
-mottled, lacey, palpable purpura -livedo reticularis -fever, headache, wt loss -joint pain -GI- bloody stool, ab pain -heart- MI, HTN -stroke- if pt comes in with suspected stroke -> and the c-reactive protein, ANA, ESR -> suspect vasculitis -eye- reduced visual acuity -nose bleeds -lungs- bloody cough, infiltrates -kidneys- glomerular nephritis
28
DVT/PE
DVT: blood clots in veins in legs and can lead to PE in arteries D-Dimer: -Cross linked fibrin generation -Elevated in setting of DVT/PE however not specific! -Can help to rule out only: negative results = NO PE -is there a hypercoagulable state?
29
stroke
Work-up: -No diagnostic lab for stoke, no organ marker -Hypercoagulable work up: check PT/INR, PTT** -initiate anti-platelet therapy Ischemic stroke: blood supply cut off - MC - caused by atherosclerosis, Antiphospholipid syndrome (prothrombotic condition), thrombus, TIA, emboli Hemorrhagic: lack of blood flow due to hemorrhage - HTN: weakens arteries over time - AV malformations - Brain aneurysms
30
acute coronary syndrome event flow chart (low risk)
Ischemic chest pain pattern- STEMI, NSTEMI, unstable angina 1) manage them assuming ACS: do a EKG within 10 minutes, get troponin levels, BMP, chest xray 2) check troponin levels - yes = tx; no = move to next step 3) calculate the HEART pathway risk score: - Score: 0 = noncardiac chest pain - score 1+: need to obtain 2ND TROPONIN 3H after 1st one -> yes = tx; no = move to next step 4) recalculate HEART risk score - 0-3: evaluate other causes of chest pain - 3+: need to obtain a non-invasive eval prior to discharge
31
overview of approach for suspected acute MI in ED
pt comes in with pattern of MI chest pain 1) manage them assuming ACS: do a EKG within 10 minutes, get troponin levels, BMP, chest xray
32
TIMI score
The TIMI Risk Score for UA/NSTEMI estimates mortality for patients with unstable angina and non-ST elevation myocardial infarction (MI).
33
HEART score for chest pain
SCORE: - tells you the risk of major adverse cardiovascular events for chest pain pts in the ED Values: -0-3- low risk -4-6- intermediate ->7- high risk
34
cardiac biomarkers for MI
Cardiac troponin* -serial rise in troponin -elevation for days after MI - acute rise and fall pattern* -all other biomarkers of nonspecific and not helpful DDx: high troponin due to non-MI/ACS - will have ambiguous pattern of troponin change
35
troponin
-Only marker used to diagnosis a Myocardial Infarction! -Normal value is <0.01 ng/ml: + troponin = above the threshold -rises within 2-4 hrs*, peaks 10-24 hrs, drops within 1-2 weeks -Can calculate size or evolving MI (higher troponin = higher area of infarction) -Used in conjunction with clinical signs -dont need to know numbers -cardiac troponin I and cardiac troponin T -high sensitivity troponin assays have cut off that is 99th precentile of cardiac disease-free reference population
36
other causes for troponin elevation
-cardiac surgery -cocain- vasospasms -PE, stroke -hemorrhage DDx: high troponin due to non-MI/ACS - will have ambiguous pattern of troponin change
37
other markers
Poor Specificity because of wide tissue distribution: -Aspartate Aminotransaminase (AST) -Creatine phosphokinase (CK) -CK-MB* -Myoglobin -Total lactate dehydrogenase (LDH)
38
CK and CK-MB
Creatine kinase (CK) and its myocardial isoenzyme (CK-MB) -> used to be MC serologic tests for dx of MI prior to troponin - idea: muscle damage: CK enzymes will be released into bloodstream but it may also present in skeletal muscle (non-specific) -not really used anymore -Many institutions no longer offer CK-MB testing -some use CK-MB for detection of early reinfarction, although not guideline recommended
39
CK and CK-MB: why is it not used anymore?
why is it not used: -Elevations in total serum CK lack specificity for myocardial damage, which improves with measurement of the MB fraction -normal range of CK VARIES; a twofold or greater increase in the CK concentration is required for dx; issue with pts with low muscle mass Criterion can be problematic in older individuals with lower muscle mass: - may have low baseline serum total CK and, during MI, may have elevated serum CK-MB with values of total CK that rise but REMAIN WITHIN NORMAL RANGE
40
rhabdo + CK levels
Rhabdomyolysis: hallmark = elevation in CK and other serum muscle enzymes (5x upper limit of normal) -causes: sustained exercise, compartment syndrome, crush injury CK levels: -Serum CK levels at presentation: range from approximately 1500 to over 100,000 international units/L -rise: within 2 to 12 hours following the onset of MUSCLE INJURY and reaches its maximum within 24 to 72 hours - Decline: 3-5 days after cessation of muscle injury Serum half-life: 1.5 days and declines at a relatively constant rate of about 40 to 50 percent of the previous day’s value - In patients whose CK does not decline as expected -> concern for continued muscle injury or the development of a compartment syndrome
41
myoglobin
Myoglobin =ubiquitous heme protein that is rapidly released from damaged tissue because of its small size - half-life in plasma: 9 minutes (early) -Due to its early appearance in the serum, myoglobin was postulated to be a useful adjunct to either troponin or creatine kinase MB (CK-MB) for the early diagnosis of myocardial infarction (MI) -With highly sensitive cardiac troponin (cTn) assays and the use of the 99th percentile or 10 percent coefficient of variation cut-off, cTn is elevated PRIOR to elevations in myoglobin summary: - used to use myoglobin for MI because it was an early biomarker - now: troponin shows up even faster and its not used anymore - MYOGLOBIN USE IS IN RHABDOMYOLYSIS
42
lactate dehydrogenase
Commonly used in the past in combination with AST and CK-MB to diagnose an acute MI - LDH: enzyme found in all parts of the body -LDH consists of M (muscle) and H (heart) subunits that give rise to five isoenzyme - heart: LD1 and some LD2 - Red cells, kidney, stomach, and pancreas are other important sources of LD1 - LD5: skeletal muscle and liver. LD levels with MI: - rises to abnormal levels 10 hours after the onset of MI - peaks at 24 to 48 hours - remains elevated for six to eight days Troponin = more specific than LD and remain elevated for 5 to 10 days - current recommendations suggest that LD no longer has a role in the diagnosis of MI
43
congestive heart failure description, how common is it, mortality, hospitalizations etc
-only cardiovascular disease with INCREASING incidence -leading cause of hospitalizations in pts 65yo and older -5 mil pts with CHF, 400,000 new cases each year -5 year mortality 10% mild CHF- 80% end stage disease Definition: ineffective pumping of heart leading to accumulation of fluid in the lungs
44
monitoring CHF
Brain natriuretic peptide, BNP and BT-proBNP -released due to myocardial stress or fluid overload -Filling pressure defect -BNP = chronically elevated with acute elevation in setting of volume overload in CHF patients -Ordering a BNP in patients with shortness of breath can reduce uncertainty of diagnosis -normal BNP: dx of CHF is highly unlikely -useful for long term monitoring in guiding therapy, monitoring course of disease and risk stratification
45
BNP
Normal Range: - 5–1,300 pg/mL. Levels above 400 pg/mL: - indicates HF in patients with SOB Levels below 100 pg/mL: - high negative predictive value for HF - HF is unlikely if BNP is below this level -Difference by age, sex, BMI -Elevated in renal failure -Equivalent to or better predictor than CXR and P/E -Correlates with NYHA Class -Patients in the highest 25% have greater mortality at 2 years then those in lowest 25% -Can not be used with Entresto
46
pro-BNP
Age ranges for HF diagnosis -<50yrs: HF at 450 pg/mL -50-75 yrs: HF at 900 pg/mL ->75 yrs: HF at 1800 pg/mL -It has a longer half-life than BNP and is considered to have greater prognostic value regarding left ventricular function -Difference by age, sex, BMI -Elevated renal failure
47
common triggers of elevated BNP and NT-proBNP
DECKS IN CLIN LAB CLASS (8)